BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated May 21, 2021, titled "Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline ".
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated May 21, 2021, titled "Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline ".